A phase II, randomized, double-blind clinical study evaluating the safety, tolerability, and efficacy of a topical minocycline foam, FMX103, for the treatment of facial papulopustular rosacea
American Journal of Clinical Dermatology Feb 08, 2018
Mrowietz U, et al. - The purpose of this study was to illustrate the safety, tolerability, and effectiveness of a minocycline foam, FMX103, for treating patients with moderate-to-severe facial papulopustular rosacea. Findings disclosed that the topical minocycline foam, FMX103, served as an effective, safe, and well-tolerated treatment for facial papulopustular rosacea.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
